AMB timeline
Every AMB batch the index holds, newest manufacture date first, with the supplier's declared purity beside the median of the index's independent observations of the same lot.
| Lot | Compound | Manufactured | Quarter | Tests | Independent median | Spread (pp) | COA purity | Divergence (pp) | |
|---|---|---|---|---|---|---|---|---|---|
| AMB-2607-N6274 | Semaglutide | 09 Jul 2026 | 2026-Q3 | 5 | 98.09 | 0.75 | 98.50 | +0.41 | |
| AMB-2606-N5977 | Retatrutide | 01 Jun 2026 | 2026-Q3 | 3 | 98.20 | 0.14 | 98.34 | +0.14 | |
| AMB-2603-S5667 | GHRP-6 | 30 Mar 2026 | 2026-Q3 | 9 | 99.37 | 1.12 | 99.54 | +0.17 | |
| AMB-2603-C5112 | Tirzepatide | 19 Mar 2026 | 2026-Q3 | 13 | 97.88 | 0.98 | 98.26 | +0.38 | |
| AMB-2602-G4870 | Oxytocin | 28 Feb 2026 | 2026-Q2 | 3 | 99.44 | 0.71 | 99.30 | -0.14 | |
| AMB-2602-P5987 | TB-500 | 20 Feb 2026 | 2026-Q3 | 2 | 99.70 | 0.33 | 99.90 | +0.20 | |
| AMB-2602-G6500 | L-Glutathione (reduced) | 17 Feb 2026 | 2026-Q1 | 3 | 99.79 | 0.20 | 99.90 | +0.11 | |
| AMB-2602-L4999 | Tirzepatide | 09 Feb 2026 | 2026-Q2 | 3 | 99.58 | 0.64 | 99.55 | -0.03 | |
| AMB-2602-Y6433 | Epitalon | 06 Feb 2026 | 2026-Q3 | 4 | 99.23 | 0.33 | 99.42 | +0.19 | |
| AMB-2601-N5360 | MOTS-c | 18 Jan 2026 | 2026-Q1 | 2 | 99.57 | 0.27 | 99.90 | +0.33 | |
| AMB-2601-M5602 | PT-141 (Bremelanotide) | 10 Jan 2026 | 2026-Q2 | 10 | 99.83 | 0.48 | 99.90 | +0.07 | |
| AMB-2512-V5420 | Sermorelin | 15 Dec 2025 | 2026-Q2 | 7 | 99.11 | 0.36 | 99.25 | +0.14 | |
| AMB-2512-D5166 | SS-31 (Elamipretide) | 09 Dec 2025 | 2026-Q1 | 4 | 99.51 | 0.53 | 99.90 | +0.39 | |
| AMB-2511-N5271 | Tirzepatide | 13 Nov 2025 | 2026-Q2 | 2 | 98.66 | 0.18 | 98.80 | +0.14 | |
| AMB-2511-B5683 | Thymosin α1 | 10 Nov 2025 | 2026-Q2 | 5 | 99.11 | 1.07 | 99.16 | +0.05 | |
| AMB-2510-H5619 | Semaglutide | 01 Oct 2025 | 2025-Q4 | 8 | 98.76 | 1.50 | 99.00 | +0.24 | |
| AMB-2508-T5301 | GHRP-6 | 28 Aug 2025 | 2025-Q3 | 14 | 99.64 | 0.79 | 99.90 | +0.26 | |
| AMB-2508-C5704 | TB-500 | 27 Aug 2025 | 2026-Q1 | 2 | 99.77 | 0.22 | 99.90 | +0.13 | |
| AMB-2508-F5378 | CJC-1295 (no DAC) | 15 Aug 2025 | 2025-Q3 | 1 | 99.21 | n<2 | 99.84 | +0.63 | |
| AMB-2507-K6102 | Semaglutide | 22 Jul 2025 | 2025-Q4 | 2 | 99.45 | 0.96 | 99.50 | +0.05 | |
| AMB-2507-A5471 | CJC-1295 (no DAC) | 20 Jul 2025 | 2025-Q3 | 2 | 99.34 | 0.04 | 99.25 | -0.09 | |
| AMB-2507-S5238 | CJC-1295 (no DAC) | 01 Jul 2025 | 2025-Q3 | 13 | 99.61 | 0.49 | 99.90 | +0.29 | |
| AMB-2506-D5337 | GHRP-6 | 26 Jun 2025 | 2025-Q4 | 9 | 99.36 | 0.34 | 98.96 | -0.40 | |
| AMB-2506-G6519 | CJC-1295 (no DAC) | 10 Jun 2025 | 2025-Q4 | 4 | 99.00 | 0.50 | 99.57 | +0.57 | |
| AMB-2505-V5343 | SS-31 (Elamipretide) | 29 May 2025 | 2025-Q3 | 1 | 99.36 | n<2 | 99.79 | +0.43 | |
| AMB-2505-J6078 | Ipamorelin | 11 May 2025 | 2025-Q3 | 13 | 99.83 | 0.60 | 99.76 | -0.07 | |
| AMB-2505-L5800 | SS-31 (Elamipretide) | 08 May 2025 | 2025-Q4 | 2 | 99.69 | 0.09 | 99.90 | +0.21 | |
| AMB-2504-P6263 | Tirzepatide | 15 Apr 2025 | 2025-Q3 | 2 | 99.21 | 0.64 | 99.69 | +0.48 | |
| AMB-2503-S5891 | Semaglutide | 07 Mar 2025 | 2025-Q3 | 9 | 99.31 | 1.43 | 99.46 | +0.15 | |
| AMB-2502-A6319 | Retatrutide | 15 Feb 2025 | 2025-Q3 | 10 | 98.17 | 0.92 | 98.06 | -0.11 | |
| AMB-2412-N5535 | CJC-1295 with DAC | 25 Dec 2024 | 2025-Q1 | 1 | 99.17 | n<2 | 98.99 | -0.18 | |
| AMB-2411-S5560 | AOD-9604 | 30 Nov 2024 | 2025-Q2 | 13 | 99.49 | 0.88 | 99.67 | +0.18 | |
| AMB-2411-G5528 | Semax | 29 Nov 2024 | 2024-Q4 | 7 | 99.92 | 0.40 | 99.90 | -0.02 | |
| AMB-2411-X6617 | Epitalon | 28 Nov 2024 | 2025-Q2 | 8 | 99.92 | 0.25 | 99.90 | -0.02 | |
| AMB-2409-L5826 | Ipamorelin | 22 Sep 2024 | 2024-Q4 | 4 | 99.56 | 0.17 | 99.43 | -0.13 | |
| AMB-2309-P5844 | Tirzepatide | 05 Sep 2023 | 2024-Q1 | 3 | 98.23 | 0.31 | 98.46 | +0.23 |